Cuproptosis in lung cancer: mechanisms and therapeutic potential
Authors:
- 22 July 2023
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 479 (6) , 1487-1499
Abstract
Cuproptosis, a recently identified form of cell death that differs from other forms, is induced by the disruption of the binding of copper to mitochondrial respiratory acylation components. Inducing cell cuproptosis and targeting cell copper death pathways are considered potential directions for treating tumor diseases. We have provided a detailed introduction to the metabolic process of copper. In addition, this study attempts to clarify and summarize the relationships between cuproptosis and therapeutic targets and signaling pathways of lung cancer. This review aims to summarize the theoretical achievements for translating the results of lung cancer and cuproptosis experiments into clinical treatment.Keywords
Funding Information
- Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX21-3108)
- “Six-one” Project for High-level Health Talents (LGY2016037)
This publication has 120 references indexed in Scilit:
- Lysyl Oxidase, Extracellular Matrix Remodeling and Cancer MetastasisCancer Microenvironment, 2012
- Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53Journal of Biological Chemistry, 2011
- Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesisProceedings of the National Academy of Sciences, 2010
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicityProceedings of the National Academy of Sciences, 2010
- HIF-1: upstream and downstream of cancer metabolismCurrent Opinion in Genetics & Development, 2010
- Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B: Emerging rolesThe International Journal of Biochemistry & Cell Biology, 2010
- N′1,N′3-Dimethyl-N′1,N′3-bis(phenylcarbonothioyl) Propanedihydrazide (Elesclomol) Selectively Kills Cisplatin Resistant Lung Cancer Cells through Reactive Oxygen Species (ROS)Cancers, 2009
- Mice with heterozygous deficiency of lipoic acid synthase have an increased sensitivity to lipopolysaccharide-induced tissue injuryJournal of Leukocyte Biology, 2008
- Molecular characteristics of immunogenic cancer cell deathCell Death & Differentiation, 2007
- The Steap proteins are metalloreductasesBlood, 2006